New technique improves T cell-based immunotherapies for solid tumors Scripps Research scientists help T cells more effectively kill solid tumors cells in vitro and in mice by tweaking an existing cancer immunotherapy.
May 01, 2024
LA JOLLA, CA Scientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors such as in melanoma, breast, and prostate cancer so T cells can more effectively kill tumor cells. They report in the journal Nature Biomedical Engineering on May 1, 2024, that this tweak allows T cells to get closer to their targets, which dramatically improves T-cell killing of tumor cells in mouse models.
Compared to blood tumors, solid tumors are resistant to treatment because they build a physical fort around themselves to block immune cells from entering and attacking. Part of this fort is made up of layers of sugar molecules, the outermost of which is a substance called sialic acid. To remove this sialic acid barrier, the research team fused the enzyme sialidase onto cancer therapy agents called bispecific T-cell engager (BiTE) molecules. These molecules typically work by activating a patient's own T cells against the cancer.
Solid tumors form a microenvironment around themselves that is immunosuppressive, says senior author Peng Wu, PhD, a professor in the Department of Molecular Medicine at Scripps Research. Immune cells have to enter this solid mass which is covered with sialic acid molecules that physically block T cells from infiltrating. The idea here is to introduce sialidase to the T-cell engager to chop off sialic acid from the outside of the tumor mass so that T cells have a better chance to enter.
BiTE molecules have two binding sites one that binds to molecules on tumor cell surfaces called antigens, and one that binds to the T-cell receptor complex. Several BiTE therapies are already FDA-approved, but they all target blood cancers (such as blinatumomab, which targets B-cell leukemia). However, clinical trials against solid tumors, which make up 90% of tumors, have had limited success.
All of the approved drugs for T-cell engager molecules are against blood tumors, because all of the BiTE clinical trials against solid tumors have been pretty underwhelming, says first author Zhuo Yang, PhD, who recently completed his PhD at Scripps Research under the guidance of Wu and the late Richard Lerner, MD. Were really hoping the strategy that we present here may have the potential to make a breakthrough for T-cell engaging therapies against solid tumors.
The researchers tested the fusion of sialidase to several different BiTE molecules targeting different types of cancer, including antigens associated with breast, B-cell and prostate cancers. In all cases, the addition of sialidase to create these fusion molecules improved T-cell killing in a lab dish (in vitro). In collaboration with Rutgers University, the research used fluorescent microscopy to show that these fusion molecules resulted in a much larger contact area (or immunological synapse ) between T cells and the tumor cells that enables better tumor killing.
Next, the researchers tested the fusion molecule's efficacy at treating solid tumors in mice. They found that mice that were treated with the fusion molecule had delayed tumor growth, smaller tumors, and were more likely to survive compared to mice treated with regular BiTE molecules. In one of the cancer models, treatment with the fusion molecule completely eradicated the tumors for two out of five mice.
The researchers also observed an altered microenvironment surrounding the tumor, which they credit with these improved treatment outcomes. In the presence of the fusion molecule, we have better infiltration of T cells and natural killer cells, which are good cells for killing tumors, and less accumulation of immunosuppressive cells, says Wu. So basically, the fusion molecule can convert an immunosuppressive tumor microenvironment into a more immune-permissive one.
Though the team hypothesized that adding sialidase would improve T-cell engagement, they were surprised by how much of a difference it made. By simply cutting off one single sugar thats overexpressed on the surface of tumor cells, we can have huge enhancements, says Yang. There are many sugars on the surface of tumor cells and we're only getting rid of the first layer, so we were not expecting to see such dramatic effects.
Eventually, the researchers hope that their technology will help treat human cancer patients, but first they will need to engineer the molecules to make them more suitable for humans. They also hope to inspire more cancer researchers to consider sugars when designing therapeutics.
Tumor cells have unique sugar patterns, but people rarely consider them, says Wu. Were hoping that in the future more and more people will think about sugars when they are designing therapeutic strategies.
In addition to Wu and Yang, authors of the study, Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager, include Yingqin Hou, Geramie Grande, Chao Wang, Yujie Shi, Jaroslav Zak, Yue Wan, Ke Qin, John R. Teijaro, and the late Richard A. Lerner of Scripps Research; and Jong Hyun Cho and Dongfang Liu of Rutgers University-New Jersey Medical School.
This work was supported by the NIH and a Cancer Research Institute/Irvington postdoctoral fellowship.
Cancer Wu, Peng
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
04/08/2026
Dalet, a leading technology and service provider for media-rich organizations, t...
04/07/2026
April 7 2026, 19:00 (PDT) Detective Conan: Fallen Angel of the Highway Opens in...
14/06/2026
Library captures 1960s R&B/pop drum sound
Following on from their recent wave of plug-in effects, Iconic Instruments have just launched an all-new virtual d...
14/06/2026
HBO Comedy Rooster Shot with URSA Cine 17K 65
Brie Clayton June 14, 2026
0 Comments
Large format brings viewers intimately close to characters.
Black...
13/06/2026
Latest expansion pack includes 252 presets
Devious Machines have recently introduced another expansion for their powerful multi-effects plug-in, Infiltrator...
13/06/2026
Create custom DAW/plug-in controllers using prompts
MetaGrid have recently introduced an all-new AI Builder function to their touchscreen-based control surf...
13/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
13/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
YES Network and The Gotham Sports App will air seven Athletes Unlimited Softball...
12/06/2026
The United Football League will host its FAST Innovation Suite at the 2026 United Bowl presented by Credit One Bank on Saturday, June 13 at 3:00 p.m. ET at Audi...
12/06/2026
PTZOptics and LayerJot will present live demonstrations at InfoComm 2026 showing how natural-language AI prompting, robotic camera control, and on-device comput...
12/06/2026
MultiDyne Video and Fiber Optic Systems will exhibit at InfoComm 2026, featuring...
12/06/2026
Ateme has announced that Eurovision Services is using Ateme's software-based frame-rate conversion technology for international live event workflows. The de...
12/06/2026
Bitmovin and Simplestream have announced a partnership with Xperi to simplify the launch of OTT streaming services on TiVo OS smart TVs and devices. The collabo...
12/06/2026
Net Insight has announced that a multinational technology company is deploying a...
12/06/2026
MLB Players Inc., the business arm of the MLB Players Association, has announced a partnership with Athletes First to develop and sell brand partnerships across...
12/06/2026
Guntermann and Drunck (G&D) and VuWall have announced the CommandKeyboard-Advanc...
12/06/2026
Comcast Smart Solutions announces a new smart technology deployment with Major L...
12/06/2026
Elevation Worship completed the initial leg of its Elevation Nights 2026 tour ...
12/06/2026
AJA Video Systems has announced KONA IP25 support for Colorfront Transkoder and ...
12/06/2026
Audinate Group Limited (ASX: AD8) will exhibit at InfoComm 2026 (Booth C7321, Ce...
12/06/2026
Pac-12 Commissioner Teresa Gould has announced the appointment of Scott Adametz as Chief Technology Officer. The Pac-12 describes the hire as the first CTO appo...
12/06/2026
Grass Valley has announced AMPP Edge Live, a production system combining Grass Valley hardware, NVIDIA Blackwell GPU acceleration, and AMPP OS in a single platf...
12/06/2026
At one time a trailblazer with the launch of the Longhorn Network, the Universit...
12/06/2026
Ratings Roundup is a rundown of recent rating news and is derived from press rel...
12/06/2026
Chyron has announced PAINT 10.4, an update to its illustrated replay and sports ...
12/06/2026
SVP, Production, Mark Gross: With the new schedule, with not having every Sunday night, it has given us an opportunity to take a step back and reimagine what o...
12/06/2026
For Televisa Technical Engineering Manager Roberto N nez Ibarra and the small team of 12 technicians and two production personnel at the IBC things are already ...
12/06/2026
Simple Steps to Better Acoustics - Taming The Small Room
Most of us mix in spare rooms and small spaces, where the acoustics fight us at every turn. At Gear...
12/06/2026
Latest addition expands vintage-inspired effects palette
Meris' Ottobit pedal range draws its inspiration from vintage gaming consoles, and the latest a...
12/06/2026
Soundbox-based chamber strings series expanded
Sonora Cinematic have just announced the launch of the second instalment in their Soundbox-based chamber stri...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
AJA Announces KONA IP25 Integration with Colorfront Software
Brie Clayton June 12, 2026
0 Comments
Collaboration enables uncompressed SMPTE ST 2110 I/O ...
12/06/2026
URSA Cine 12K LF Used to Create Visuals for STUTS' K-Arena Concert
Brie Clayton June 12, 2026
0 Comments
Organic visuals projected on a giant scre...
12/06/2026
MTI FILM Acquires Mango New Edit, Expanding its Global Post-Production Services ...
12/06/2026
AI Point Tracking Speeds Up Complex VFX Tracks in Mocha Pro
Jessie Electa Petrov June 12, 2026
0 Comments
The 2026.5 release adds automatic point trac...
12/06/2026
Bitmovin, a provider of video streaming solutions, has partnered with Simplestream, a provider of OTT and broadcast solutions, and technology provider Xperi, to...
12/06/2026
Leostream Corporation, creator of the world-leading Leostream Remote Desktop Access Platform, today announced Jigsaw24, a leading B2B IT solutions provider wit...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
Share
Copy link
Facebook
X
Linkedin
Bluesky
Email...
12/06/2026
How Aussie indie games and screen are levelling up with IP 11 June 2026
Ari Harrison, Pro Jank Footy
Head of Games Joey Egger and Ari Harrison of Umbrella sha...
12/06/2026
AgentPerf from Artificial Analysis, the industry's first agentic AI benchmark, gives developers, enterprises and infrastructure providers a clear way to com...
12/06/2026
Back to All News
Netflix Unveils First-Look Images from Villaflor, Santiago Mitre's New Film
Entertainment
12 June 2026
GlobalArgentina
Link copied to ...
New technique improves T cell-based immunotherapies for solid tumors Scripps Research scientists help T cells more effectively kill solid tumors cells in vitro and in mice by tweaking an existing cancer immunotherapy.
